# BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.

> **NCT04231929** · NA · WITHDRAWN · sponsor: **Terumo Europe N.V.**

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** Chemoembolization

## Key facts

- **NCT ID:** NCT04231929
- **Lead sponsor:** Terumo Europe N.V.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05
- **Primary completion:** 2021-03
- **Final completion:** 2023-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study cancelled by Sponsor decision
- **Last updated:** 2022-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04231929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04231929, "BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04231929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*